-
Mashup Score: 0NIH Bids Dr. Fauci Farewell - 1 year(s) ago
Virtual farewell event to celebrate the remarkable career of Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases. For more information, please visit: https://employees.nih.gov/pages/farewell-dr-fauci.aspx
Guest of Honor:
- Anthony Fauci, M.D., Director,…
Source: NIH VideoCastingCategories: Hem/Oncs, Latest HeadlinesTweet - Anthony Fauci, M.D., Director,…
-
Mashup Score: 8It Ain’t Over Till It’s Over…but It’s Never Over — Emerging and Reemerging Infectious Diseases | NEJM - 1 year(s) ago
Perspective from The New England Journal of Medicine — It Ain’t Over Till It’s Over…but It’s Never Over — Emerging and Reemerging Infectious Diseases
Source: New England Journal of MedicineCategories: Infectious Disease, Latest HeadlinesTweet-
Great perspective by #Fauci from his tenure as director of #NIAID - he touches on #HIV #Ebola #COVID19 and much more https://t.co/nrE5Mh0Zx1 https://t.co/MNKqFfdale
-
-
Mashup Score: 5Dr Fauci and the Art of Science Communication - 2 year(s) ago
Anthony Fauci, MD, who announced he will step down as chief medical advisor to US President Joe Biden and as director of the National Institute of Allergy and Infectious Diseases, discusses best practices for conveying scientific information to the public in a polarized era.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#NIAID Director Anthony Fauci, MD, discusses best practices for conveying scientific information to the public in a polarized era in conversation with @KBibbinsDomingo. Fauci has announced he will step down from #NIAID after nearly 40 years. https://t.co/QwprSslQ7L
-
-
Mashup Score: 6
The practice of “drug-checking” — essentially, testing illicit drugs to see if they contain unknown toxins — has remained controversial even as the crisis of fentanyl deaths has attracted national attention.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
1. #NIAID is launching its clinical trial of Jynneos, the Bavarian Nordic #monkeypox vaccine. I wrote about the fact that they were working on designing this clinical trial back in early August. A short 🧵 https://t.co/rthktnK9bM
-
-
Mashup Score: 05 Monkeypox Myths We Need To Stop Believing - 2 year(s) ago
Misinformation about the viral disease is everywhere. Here are the real facts you should know, from how it spreads to who is at risk.
Source: HuffPostCategories: Hem/Oncs, Latest HeadlinesTweet-
.#Monkeypox. Myths & Misconceptions. Know the truth about how the disease spreads, who it infects and how deadly it is. Experts set the record straight and correct some of the monkeypox #misinformation that has circulated recently. https://t.co/w3mC5K4q0I #NIAID #NIHCEAL @nihceal https://t.co/l325Nj1P7t
-
-
Mashup Score: 0Moderna's Vaccine for Children 6 Months to 6 Years Meets Primary Endpoint in Phase 2/3 - 2 year(s) ago
The dose is half the antigen amount for adults but with similar amount of titers.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
The dose has similar amount of titers, but it is half the antigen amount for adults. https://t.co/r2L6SyPkqr #moderna #covid #covid19 #vaccine #NIAID #NIH #BARDA #kidcove #FDA
-
-
Mashup Score: 1NIH Makes Substantial New Investment in HIV Cure Research - 3 year(s) ago
Cross-posted from NIAID NewsroomAdditional Funding Includes Effort Focused on Pediatric PopulationsThe National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research program
Source: HIV.govCategories: HIV/AIDS, Latest HeadlinesTweet-
#ICYMI: @NIH awarded $53M in funding over the next five years to support HIV cure research. One of the grants will focus on #HIV cure research in infants and children. Learn more. https://t.co/J1y2yn2Fen #NIAID #EndHIV
-
-
Mashup Score: 0Determining the Biomarkers of COVID-19 Outcome and Severity - 3 year(s) ago
National Institute of Allergy and Infectious Disease (NIAID) has selected Metabolon to participate in a study on this subject.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
"It's an honor to collaborate with #NIAID and participating researchers across the U.S. on the #IMPACC study to assess and precisely characterize the impact of SARS-CoV-2 on health," Greg Michelotti, PhD, the scientific director of #Metabolon, said. https://t.co/YMQABMbkUZ
-
-
Mashup Score: 0Determining the Biomarkers of COVID-19 Outcome and Severity - 3 year(s) ago
National Institute of Allergy and Infectious Disease (NIAID) has selected Metabolon to participate in a study on this subject.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Metabolon, a biotechnology company based in Durham, North Carolina, has been selected by the #NIAID to participate in a study on #COVID19 https://t.co/YMQABLTJwp
-
-
Mashup Score: 0
Outreach will focus on COVID-19 awareness and education research, especially among African Americans, Hispanics/Latinos, and American Indians.
Categories: Cardiologists, Latest HeadlinesTweet-
.@NIH-wide effort to address misinformation and distrust through community engagement and research. #partnerships #community-based organizations, research investigators. #nihCEAL #CEAL #NHLBI #NIMHD #NIAID #NCATS @AllofUsResearch #Tribal #COVID19 #vaccine https://t.co/9MyMCyBl0b
-
.@NIH virtual farewell to celebrate the remarkable career of Dr. Anthony Fauci, Director, #NIAID. A giant in clinical medicine and #PublicHealth #HIVAIDS #COVID19 @NIAIDCareers @NIAIDFunding @NIAIDNews #Fauci Friday, December 16, 2022, 1:00 PM (EST) Video: https://t.co/Rilky7xOA1 https://t.co/h1xtXIHhVQ